This Pharmaceutical Manufacturing Industry Focused eBook covers industry challenges and opportunities, from advances in biologics to increasing regulatory pressures and the demand for more efficient, scalable manufacturing.
This edition brings together industry content exploring the technologies, trends, and strategies shaping pharmaceutical production today.
What’s inside this eBook?
Topics covered in this edition include:
- Biologics and advanced therapies
- Process optimization and scale-up
- Automation and digital manufacturing
- Aseptic processing and contamination control
- Regulatory and compliance challenges
Who is this eBook for?
This eBook is aimed at professionals working across pharmaceutical manufacturing, including:
- Process and manufacturing engineers
- Bioprocessing specialists
- Quality and regulatory professionals
- R&D scientists
- Operations and production teams
Download the eBook
Explore the latest developments in pharmaceutical manufacturing and hear from experts across the industry.
About Lonza
Lonza is one of the world’s largest contract development and manufacturing organizations (CDMOs) dedicated to serving the healthcare industry. Working across five continents, our global team of approximately 20,000 colleagues works alongside pharma and biotech companies to turn their breakthrough innovations into viable therapies. We support our customers in bringing life-saving and life-enhancing treatments to patients worldwide with a combination of cutting-edge science, smart technology, and lean manufacturing.
Our company generated sales of CHF 6.5 billion with a CORE EBITDA of CHF 2.1 billion in Full-Year 2025.
Find out more at www.lonza.com.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices, and treatments.